Mode
Text Size
Log in / Sign up
N/A N=2,600 Screening

The National CT Colonography Trial

Colorectal Cancer

Enrolled (actual)
2,600
Serious AEs
0.0%
Results posted
Nov 2020
Primary outcome: Primary: Number of Participants With Advanced Adenomas (>=10mm) as Determined by Colonoscopy (Per Patient) — 109; 2422 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
CT Colonography (Procedure)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
American College of Radiology Imaging Network
Primary completion
Sep 2007

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Advanced Adenomas (>=10mm) as Determined by Colonoscopy (Per Patient)
109; 2422
PRIMARY
Number of Participants With Advanced Adenomas (>=9mm) Detected by CT Colonoscopy (Per Patient)
120; 2411
PRIMARY
Number of Participants With Advanced Adenomas (>=8mm) Detected by CT Colonoscopy (Per Patient)
154; 2377
PRIMARY
Number of Participants With Advanced Adenomas (>=7mm) Detected by CT Colonoscopy (Per Patient)
174; 2357
PRIMARY
Number of Participants With Advanced Adenomas (>=6mm) Detected by CT Colonoscopy (Per Patient)
210; 2321
PRIMARY
Number of Participants With Advanced Adenomas (>=5mm) Detected by CT Colonoscopy (Per Patient)
282; 2249
SECONDARY
Number of Advanced Adenoma or Cancer Lesions (>=10mm) Detected by CT Colonoscopy (Per Lesion)
108; 20
SECONDARY
Number of Advanced Adenoma or Cancer Lesions (>=9mm) Detected by CT Colonoscopy (Per Lesion)
117; 26
SECONDARY
Number of Advanced Adenoma or Cancer Lesions (>=8mm) Detected by CT Colonoscopy (Per Lesion)
149; 38
SECONDARY
Number of Advanced Adenoma or Cancer Lesions (>=7mm) Detected by CT Colonoscopy (Per Lesion)
165; 55
SECONDARY
Number of Advanced Adenoma or Cancer Lesions (>=6mm) Detected by CT Colonoscopy (Per Lesion)
189; 81
SECONDARY
Number of Advanced Adenoma or Cancer Lesions (>=5mm) Detected by CT Colonoscopy (Per Lesion)
221; 153
SECONDARY
Interobserver Sensitivity Variability
0.94; 0.88

Summary

RATIONALE: New diagnostic procedures such as computed tomographic colonography may improve the ability to detect colorectal cancer and may provide a less invasive method of detection. PURPOSE: This clinical trial is studying how well computed tomographic colonography works in screening healthy participants for colorectal cancer.

Eligibility Criteria

  • Inclusion Criteria
  • Male or female outpatients
  • Aged 50 years or older
  • Scheduled for screening colonoscopy
  • Participant's signed informed consent
  • Exclusion Criteria
  • Symptoms of disease of the lower gastrointestinal tract, including
  • Melanotic stools or/and hematochezia on more than one occasion in the previous six months
  • Lower abdominal pain that would normally require a medical evaluation
  • Inflammatory bowel disease and/or familial polyposis syndrome
  • Serious medical conditions that would increase the risk associated with colonoscopy or are so severe that screening would have no benefit
  • Pregnancy
  • Previous colonoscopy within the past five years
  • Anemia (hemoglobin less than 10 gm/dl)
  • Positive fecal occult blood test (FOBT)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00084929). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search